ClinicalTrials.gg
RecruitingNCT07364500Updated Nov 3, 2026

Protocol-driven Nutrition in Preterm Infants

An interventional study of Nutrition plan supported by advanced clinical nutrition software in Preterm Infants, sponsored by Institute of Health Information and Statistics of the Czech Republic. Recruiting at 5 sites in Czechia. Open to participants aged 22 Weeks to 32 Weeks. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Institute of Health Information and Statistics of the Czech Republic · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Aug 2025, registered Jan 2026).
  • Started Aug 2025; still recruiting 1 year 3 months later.
Updated Nov 3, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Not applicable
Ages
22 Weeks to 32 Weeks
Sex
All
01

Study summary

The project is a national, prospective, multicenter, interventional pilot project focused on protocol-driven nutrition in preterm infants in the Czech republic.

The primary aim of the project is to prepare, test, and develop a proposal for a national methodology for the care of preterm newborns in the field of nutrition. This will reduce health risks in premature infants and minimize the negative impacts on the overall development of the child and the family of the premature infant.

Read the detailed description

The project is a national, prospective, multicenter, interventional pilot project focused on protocol-driven nutrition in preterm infants in the Czech republic.

The main goal of the project is standardization of nutrition of premature newborns across healthcare facilities with the aim to optimize postnatal growth and reduce complications associated with prematurity through individualized and closely monitored nutritional plans.

The project will be running in 5 perinatology centers in the Czech Republic. It is expected that 400 premature infants will participate. The project is supported by the European Social Fund (Operational Program Employment Plus) and the state budget of the Czech Republic and is registered by the Ministry of Labour and Social Affairs of the Czech Republic under ID: CZ.03.02.02/00/22_005/0002020. The study has been reviewed and approved by multiple local ethical committees. The listed IRB represents the lead national ethical committee overseeing the trial.

02

Conditions studied

  • Preterm Infants

Keywords

  • preterm infants
  • nutrition of preterm infants
  • human milk analysis
  • nutrition monitoring
  • Czech Republic
03

In context

Lead sponsor

Institute of Health Information and Statistics of the Czech Republic is the lead sponsor of 14 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Weeks to 32 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants born before 31+6 weeks gestation.
  • Signed consent for participation in the project and consent for the processing of personal data.
  • Admission to neonatal care in the participating hospital within 24 hours after birth.

Exclusion criteria

Exclusion Criteria:

  • Congenital malformations.
  • Fetal hydrops.
  • Intraventricular hemorrhage requiring drainage.
  • Necrotizing enterocolitis requiring surgical treatment.
  • Surgically treated hydrocephalus.
  • Unsigned consent for participation in the project and/or consent for the processing of personal data.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
400 participants (estimated)

Study arms

  • Other
    Preterm infants

    The nutritional management of enrolled patients will be guided by individualized plans developed by attending physicians, supported by advanced clinical nutrition software enabling precise monitoring and adjustment based on ongoing anthropometric and dietary data.

    Dietary Supplement: Nutrition plan supported by advanced clinical nutrition software

Interventions

  • Dietary supplementNutrition plan supported by advanced clinical nutrition software

    Infants undergo regular anthropometric assessments (weight, length, head circumference), and detailed fluid and nutrient intake is recorded. Weekly analysis of the macronutrient composition of maternal or donor milk is conducted, enabling personalized fortification to meet the infant's current needs. The intervention utilizes a dedicated nutrition software tool, incorporating Fenton growth charts, to support clinical decisions and track progress via z-scores compared to term-born infants. By aligning nutrient supply with individual requirements and promoting early enteral feeding, the project seeks to enhance growth outcomes, minimize risks such as bronchopulmonary dysplasia or retinopathy, and shorten the length of stay in neonatal intensive care.

06

What researchers measure

Primary outcomes

  1. Z-score for body weight at 36 weeks corrected gestational age

    Time frame: Up to a corrected gestational age of 36 weeks

  2. Z-score for body length at 36 weeks corrected gestational age

    Time frame: Up to a corrected gestational age of 36 weeks

  3. Z-score for head circumference at 36 weeks corrected gestational age

    Time frame: Up to a corrected gestational age of 36 weeks

07

Study locations

4 of 5 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Aug 2025 (actual). Primary completion is estimated for Mar 2027, 19 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: primary completion Nov 2026 → Mar 2027 and completion Feb 2027 → Aug 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2026
First posted
Jan 23, 2026
StartActual
Aug 21, 2025
Primary completionEst.
Mar 2027was Nov 2026
CompletionEst.
Aug 2027was Feb 2027
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Nov 30, 2026→Mar 2027
Nov 3, 2026
Study completion
Feb 2027→Aug 2027
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Primary completion Nov 30, 2026→Mar 2027
    Study completion Feb 2027→Aug 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07364500
Lead sponsor
Institute of Health Information and Statistics of the Czech Republic
Collaborators
General University Hospital, Prague, University Hospital Olomouc, České Budějovice Hospital, Tomáš Baťa Regional Hospital in Zlín, Brno University Hospital
Responsible party
Sponsor
First posted
Jan 23, 2026
Start date
Aug 21, 2025
Primary completion
Mar 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Nov 3, 2026

Study contacts

Daniela Dokoupilová, MSc
Contact
daniela.dokoupilova@uzis.cz
+420725441408
Lucie Mandelová, Ph.D.
Contact
lucie.mandelova@uzis.cz
+420770190828
Richard Plavka, prof.
study director · General Hospital University in Prague
Jiří Dušek, M.D., MHA
study chair · České Budějovice Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion